Eli Lilly and Co Newsroom

BofA Adds Booz Allen Hamilton and Datadog to Its US 1 List

Seeking Alpha11:28 ET

Live Stock News: Market Waiting to See if the President Says Something Exciting Today

Kevin Travers11:08 ET

Argus Research Maintains Eli Lilly and Co(LLY.US) With Buy Rating

Moomoo NewsJan 23 09:33 ET · Ratings

Jefferies Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Raises Target Price to $1,020

Moomoo NewsJan 23 08:31 ET · Ratings

Eli Lilly & Co: Buy Rating Backed by Promising Orfoglipron Trials and Strong Pharmaceutical Pipeline

TipRanksJan 23 08:16 ET · Ratings

This Weight-Loss Drug Stock Could Gain 200%. The Case for It to Challenge Novo, Lilly. -- Barrons.com

Barron'sJan 23 07:38 ET

Evercore Maintains Eli Lilly and Co(LLY.US) With Hold Rating

Moomoo NewsJan 23 05:34 ET · Ratings

DBS Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Announces Target Price $1,115

Moomoo NewsJan 23 05:34 ET · Ratings

Lilly Confirms Date and Conference Call for Fourth-quarter 2024 Financial Results and 2025 Financial Guidance Announcement

Eli Lilly & Co.Jan 23 00:00 ET

Wall Street Today: Does Anyone Have the Cash for Stargates

Kevin TraversJan 22 16:05 ET

Why Is Eli Lilly and Company (LLY) Among the Best Large-Cap Value Stocks to Buy in 2025?

Yahoo FinanceJan 22 15:59 ET

Beyond Big Tech: 20 Stocks to Ride the AI Trend

MarketWatchJan 22 12:26 ET

Top SA Quant-rated Medical Devices Stocks as Technicals Look Strong

Seeking AlphaJan 22 11:44 ET

Live Stock: Stargate Rivals the Scale of the Manhattan Project, Musk Said it's a Pipe Dream

Kevin TraversJan 22 10:45 ET

Jefferies Financial: Raised Eli Lilly and Co's Target Price to $1020.

Jefferies Financial raised the Target Price for Eli Lilly and Co from $996 to $1020.

Gelonghui FinanceJan 22 09:20 ET

Express News | Eli Lilly : Jefferies Raises Target Price to $1020 From $996

ReutersJan 22 09:18 ET

GLP-1 Drugs Cut Risk of Alzheimer's, NVO & LLY Shares Rise

Zacks Jan 22 08:00 ET

Google Parent-Owned Startup To Launch AI-Designed Drug Trials By Year-End, Partnering With Eli Lilly And Novartis To Tackle Major Diseases

BenzingaJan 22 01:44 ET

The speed of drug research and development has increased by ten times! Google states that the first AI-designed medication will enter testing by the end of the year.

Demis Hassabis, the founder of Google's drug development company, stated that traditional drug development usually takes 5 to 10 years, while with the help of AI technology, this process may be accelerated by 10 times. Former USA Treasury Secretary Summers once commented that AI's relationship with the Internet Plus-Related is similar to that of computers with calculators.

wallstreetcnJan 21 21:36 ET

Wall Street Today: AI Domestic Investment News on the Way

Kevin TraversJan 21 16:42 ET